mGlu5 receptor antagonists: A novel class of anxiolytics?

Drug News and Perspectives

Volumn 17, Issue 4, 2004, Pages 251-257

  Spooren, Will ^a   Gasparini, Fabrizio ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 6 METHYL 2 PHENYLAZO 3 PYRIDINOL; AMPA RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; EGLUMETAD; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMINO ACID SEQUENCE; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; DRUG BINDING SITE; DRUG MECHANISM; DRUG PENETRATION; HUMAN; NEUROTRANSMITTER RELEASE; NONHUMAN; REVIEW; SECOND MESSENGER; SYNAPTIC TRANSMISSION; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BINDING SITES; BRAIN CHEMISTRY; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; PYRIDINES; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 3342946097     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2004.17.4.829052     Document Type: Review

References (36)

1. Dingledine, R., Borges, K., Bowie, D. and Traynelis, S.F. The glutamate receptor ion channels. Pharmacol Rev 1999, 51: 7-61.
2. Sladeczek, F., Pin, J.P., Recasens, M., Bockaert, J. and Weiss, S. Glutamate stimulates inositol phosphate formation in striatal neurons. Nature 1985, 317: 717-9.
3. Nicoletti, F., Ladarola, M., Wroblenski, J.T. and Costa, E. Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: Developmental changes and interaction with alpha 1-adrenoreceptors. Proc Natl Acad Sci USA 1986, 81: 1931-5.
4. Sugiyama, H., Ito, I. and Hirono, C. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature 1987, 325: 531-3.
5. Houamed, K.M., Kijper, J.L., Gilbert, T.L., Haldeman, B.A., Mulvihill, E.R., Almers, W. and Hagen, F.S. Cloning, expression and gene structure of a G protein-coupled glutamate receptor from rat brain. Science 1991, 252: 1318-21.
6. Masu, M., Tanabe, Y., Tsuchida, K., Shigemototo, R. and Nakanishi, S. Sequence and expression of a metabotropic glutamate receptor. Nature 1991, 349: 760-5.
7. Conn, P.J. and Pinn, J.P. Pharmacology and functions of metabotropic glutamate receptors. Ann Rev Pharmacol Toxicol 1997, 37: 205-37.
8. Hermans, E. and Challiss, R.A.J. Structural, signalling and regulatory properties of group I metabotropic glutamate receptors: Prototypic family C G-protein-coupled receptors. J Biochem 2001, 359: 465-84.
9. Kunishima, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H. and Morikawa, K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000, 407: 971-7.
10. Galvez, T., Parmentier, M.L., Joly, C., Malitschek, B., Kaupmann, K., Kuhn, R., Bittiger, H., Froestl, W., Bettler, B. and Pin, J.P. Mutagenesis and modeling of the GABAB receptor extracellular domain support a Venus flytrap mechanism for ligand binding. J Biol Chem 1999, 274: 13362-9.
11. Shigemoto, R., Nomura, S., Ohishi, H., Sugihara, H., Nakanishi, S. and Mizuno, N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 1993, 163: 53-7.
12. Romano, C., Sesma, M.A., McDonald, C.T., O'Malley, K., Van den Pol, A.N. and Olney, J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 1995, 355: 455-69.
13. Shigemoto, R. and Mizuno, N. Metabotropic glutamate receptors- Immunocytochemical and in situ hybridization analysis. In: Handbook of Chemical Neuroanatomy, Ottersen and Strom-Mathisen (Eds.), Elsevier Amsterdam (The Netherlands), 2000, 63-98.
14. Varney, M.A., Cosford, N.D., Jachec, C., Rao, S.P., Sacaan, A., Lin, F.F., Bleicher, L., Santori, E.M., Flor, P.J., Allgeier, H., Gasparini, F., Kuhn, R., Hess, S.D., Velicelebi, G. and Johnson, E.C. SIB-1757 and SIB-1893: Selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J Pharmacol Exp Ther 1999, 290: 170-81.
15. Gasparini, F., Lingenhohl, K., Stoehr, N., Flor, P.J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendom, R., Urwyler, S., Varney, M.A., Johnson, E.C., Hess, S.D., Rao, S.P., Sacaan, A.I., Santori, E.M., Velicelebi, G. and Kuhn, R. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 1999, 38: 1493-503.
16. Spooren, W.P., Gasparini, F., Salt, TE. and Kuhn, R. Novel allosteric antagonists shed light on mGlu(5) receptors and CNS disorders. Trends Pharmacol Sci 2001, 22: 331-7.
17. Pagano, A., Ruegg, D., Litschig, S., Stoehr, N., Stierlin, C., Heinrich, M., Floersheim, P., Prezeau, L., Carroll, F., Pin, J.P., Cambria, A., Vranesic, I., Flor, P.J., Gasparini, F. and Kuhn, R. The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a- carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors. J Biol Chem 2000, 275: 33750-8.
18. Bissantz, C., Bernard, R., Hibert, M. and Rognan, D. Protein based virtual screening of chemical databases. 11. Are homology models of G-protein coupled receptors suitable targets? Proteins 2003, 50: 5-25.
19. Spooren, W.P., Vassout, A., Neijt, H.C., Kuhn, R., Gasparini, F., Roux, S., Porsolt, R.D. and Gentsch, C. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 2000, 295: 1267-75.
20. Tatarczynska, E., Klodzinska, A., Chojnacka-Wojcik, E., Palucha, A., Gasparini, F., Kuhn, R. and Pilc, A. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 2001, 132: 1423-30.
21. Spooren, W.P.J.M., Schoeffter, P., Gasparini, F., Kuhn, R. and Gentsch, C. Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 2002, 435: 161-70.
22. Brodkin, J., Bradbury, M., Busse, C., Warren, N., Bristow, L.J. and Varney, M.A. Reduced stress-induced hyperthermia in mGluR5 knockout mice. Eur J Neurosci 2002, 16: 2241-4.
23. Schwarz, R.D., Dickerson, M., Gillespie, K., Kinsora, J. and Lotarski, S. mGluR group I antagonists for the treatment of anxiety. Neuropharmacology 2002, 43: 308.
24. Brodkin, J., Busse, C., Sukoff, S.J. and Varney, M.A. Anxiolytic-like activity of the mGluR5 antagonist MPEP: A comparison with diazepam and buspirone. Pharmacol Biochem Behav 2002, 73: 359-66.
25. Spooren, W., Vivian, J. and Ballard, T. Anxiolytic-like effects of the selective mGlu5 receptor antagonist MPEP in punished responding. Neuropharmacology 2002, 43: 309.
26. Schulz, B., Fendt, M., Gasparini, F., Lingenhohl, K., Kuhn, R. and Koch, M. The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)- pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology 2001, 41: 1-7.
27. Nadlewska, A., Car, H., Wisniewska, R.J. and Wisniewski, K. Behavioral effects of the selective blockade of metabotropic glutamate receptor subtype 5 in experimental hypoxia. Pol J Pharmacol 2002, 54: 95-102.
28. Pilc, A., Klodzinska, A., Branski, P., Nowak, G., Palucha, A., Szewczyk, B., Tatarczynska, E., Chojnacka-Wojcik, E. and Wieronska, J.M. Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology 2002, 43: 181-7.
29. Spooren, W.P., Gasparini, F., Bergmann, R. and Kuhn, R. Effects of the prototypical mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. Eur J Pharmacol 2000, 406: 403-10.
30. Klodzinska, A., Chojnacka-Wójcik, E., Wieronska, J. and Pilc, A. Anxiolytic-like effects of MPEP the selective metabotropic glutamate receptor 5-mGluR5 antagonist, in rats. Pharmacological analysis. Neuropharmacology 2002, 43: 292.
31. Rodrigues, S.M., Bauer, E.P., Farb, C.R., Schafe, G.E. and LeDoux, J.E. The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala. J Neurosci 2002, 22: 5219-29.
32. Fendt, M. and Schmid, S. Metabotropic glutamate receptors are involved in amygdaloid plasticity. Eur J Neurosci 2002, 15: 1535-41.
33. Spooren, W., Ballard, T., Gasparini, F., Amalric, M., Mutel, V. and Schreiber, R. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: Behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol 2003, 14: 257-77.
34. Levine, L., Gaydos, B., Sheehan, D., Goddard, A., Feighner, J., Potter, W. and Schoepp, D. The mGlu2/3 receptor agonist, LY354740, reduces panic anxiety induced by a CO2 challenge in patients diagnosed with panic disorder. Neuropharmacology 2002, 43: 294.
35. Levine, L.R., Gaydos, B., Potter, W.Z. and Tollefson, G.D. The mGlu2/3 receptor agonist, LY354740, demonstrates anxiolytic activity in GAD. Proceed 41st Ann Meet Am Coll Neuropsychopharmacol 2002 (Dec. 8-12, San Juan, Puerto Rico).
36. Grillon, C., Cordove, J., Levine, L.R. and Morgan, C.A. Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear potentiated startle paradigm in humans. Psychopharmacology 2003, 168: 446-54.